Lantheus Holdings LNTH
NASDAQ LNTH
$100.18 -0.06 (-0.06%)
As of: Aug 21, 2026 · 3:47 PM EDT

Lantheus Holdings (LNTH) Debt Ratio (2014 - 2026)

Lantheus Holdings (LNTH) posted quarterly Debt Ratio of 0.24 for Q1 2026, down 11.87% year-over-year from 0.28 in Q1 2025, and down 4.91% quarter-over-quarter from 0.26 in Q4 2025.

Lantheus Holdings (LNTH) Debt Ratio (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Debt Ratio for 13 consecutive years, with 0.24 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Debt Ratio fell 11.87% year-over-year to 0.24; the TTM figure through Mar 2026 stood at 0.24 (down 11.87% YoY), while the FY2025 annual figure was 0.26, down 10.6% from the prior year.
  • Debt Ratio retreated to 0.24 in Q1 2026 per LNTH's latest filing, from 0.26 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.5 in Q4 2022 and bottomed at 0.15 in Q3 2022.
  • Historically, Debt Ratio has averaged 0.29 across 5 years, with a median of 0.28 in 2024.
  • On a YoY basis, Debt Ratio climbed as much as 149.88% in 2023 and fell as far as 31.53% in 2023.
  • Lantheus Holdings' Debt Ratio stood at 0.5 in 2022, then plunged by 31.53% to 0.34 in 2023, then decreased by 16.07% to 0.29 in 2024, then fell by 10.6% to 0.26 in 2025, then declined by 4.91% to 0.24 in 2026.
  • Business Quant data shows LNTH's Debt Ratio at 0.24 in Q1 2026, 0.26 in Q4 2025, and 0.25 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Haleon 44.45 Bn 43.48 Bn - -0.13
2 Teva Pharmaceutical Industries 43.50 Bn 39.84 Bn 2.15 Bn 0.42
3 Zoetis 32.42 Bn 30.75 Bn 1.05 Bn 0.60
4 Takeda Pharmaceutical 28.62 Bn 22.82 Bn 5.10 Bn 0.32
5 United Therapeutics 21.99 Bn 19.33 Bn 683.80 Mn -
6 Viatris 18.96 Bn 18.08 Bn 1.46 Bn 0.38
7 Neurocrine Biosciences 15.45 Bn 15.06 Bn 935.80 Mn -
8 Elanco Animal Health 12.03 Bn 11.50 Bn 798.00 Mn 0.29
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 0.12
10 Lantheus Holdings 6.53 Bn 5.93 Bn 241.86 Mn 0.24

Historic Data

Download Data
DateValue
Jun 30, 2026 0.24
Mar 31, 2026 0.24
Dec 31, 2025 0.26
Sep 30, 2025 0.25
Jun 30, 2025 0.27
Mar 31, 2025 0.28
Dec 31, 2024 0.29
Sep 30, 2024 0.28
Jun 30, 2024 0.29
Mar 31, 2024 0.31
Dec 31, 2023 0.34
Sep 30, 2023 0.37
Jun 30, 2023 0.42
Mar 31, 2023 0.41
Dec 31, 2022 0.50
Sep 30, 2022 0.15
Jun 30, 2022 0.17
Mar 31, 2022 0.18
Dec 31, 2021 0.20
Sep 30, 2021 0.21